Rite Aid-Walgreens Merger Update, Analysts Review, and Amazon Too?
NEW YORK, NY / ACCESSWIRE / June 16, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies, is issuing a comprehensive report with no obligation on Rite Aid Corporation (RAD), a national drugstore chain operator. Traders News Source previously covered the proposed merger with Walgreens on April 26, 2017. We discussed the many delays the deal had already experienced, and what was likely to happen next.
On May 8, 2017, Walgreens and Rite Aid certified compliance with the Federal Trade Commission's (FTC) request for additional information regarding the proposed merger. In short, this move forces the FTC to decide within 60 days whether to allow the transaction to proceed or sue to block it.
Where does the proposed merger stand? Analysts review and price target: READ MORE.
Copy and paste to your browser may be required to view the report - http://tradersnewssource.com/rad-update/.
A primary concern is that Fred's, Inc., slated to buy hundreds of Rite Aid stores, has a larger footprint that would not be able to replicate Rite Aid's market presence. On June 9th, Fred's announced that it had secured financing commitments to complete the purchase. Past failed divestiture plans in the retail sector may also spur the FTC to action. In multiple instances, companies that agreed to divest assets to receive FTC approval later bought them back when the acquirer went bankrupt. These transactions included Hertz/Dollar Thrifty (2012) and Albertsons/Safeway (2015).
To muddy the issue further, Amazon seems to be making moves toward an entry into the pharmacy market. In the United States alone, more than 4 billion prescriptions are ordered every year. In 2015, patients, insurance companies, and other payers spent an estimated $300 billion on prescription drugs. If competition really does bring products closer to cost; Amazon has the potential to be a disruptive force in the pharmacy industry.
Our full report includes the possible impact of Amazon and Fred's on the pharmacy space: READ MORE
Copy and paste to your browser may be required to view the report - http://tradersnewssource.com/rad-update/.
DISCLOSURE
Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TNS has not been compensated, directly or indirectly, for producing or publishing this document.
PRESS RELEASE PROCEDURES
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. Ivan Neilson, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at editor@tradersnewssource.com
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
CONTACT:
SOURCE: Traders News Source
